Literature DB >> 30279799

Percutaneous isolation of left atrial appendage thrombus.

Oh-Hyun Lee1, Jae-Sun Uhm1, Jung-Sun Kim1,2, In-Jeong Cho1, Geu-Ru Hong1, Hui-Nam Pak1, Yangsoo Jang1,2.   

Abstract

Most physicians regard left atrial appendage (LAA) thrombus as a contraindication for LAA occlusion due to risk of distal embolization which is a serious complication. Here we report a case of successfully implanted Amplazter cardiac plug without complication in elderly patients having LAA thrombus with recurrent embolic events despite oral anticoagulants for prevention of thromboembolic events. <Learning objective: LAA thrombus is not completely resolved in all cases and can be a potential source of stroke or embolization even during anti-coagulation. We would like to share a case that suffered from 6 strokes or embolizations despite anti-coagulation, warfarin or non-vitamin K antagonist oral anti-coagulants due to incomplete resolution of LAA thrombus. In this clinical situation, we can suggest LAA occlusion to isolate thrombus from LA and prevent further stroke or embolization.>.

Entities:  

Keywords:  Left atrial appendage occlusion; Nonvalvular atrial fibrillation; Thrombus

Year:  2017        PMID: 30279799      PMCID: PMC6149266          DOI: 10.1016/j.jccase.2017.05.002

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  5 in total

Review 1.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

2.  Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation.

Authors:  Marcus F Stoddard; Pradeep Singh; Buddhadeb Dawn; Rita A Longaker
Journal:  Am Heart J       Date:  2003-04       Impact factor: 4.749

3.  Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators.

Authors:  M Zabalgoitia; J L Halperin; L A Pearce; J L Blackshear; R W Asinger; R G Hart
Journal:  J Am Coll Cardiol       Date:  1998-06       Impact factor: 24.094

4.  The left atrial appendage: from embryology to prevention of thromboembolism.

Authors:  Giuseppe Patti; Vittorio Pengo; Rossella Marcucci; Plinio Cirillo; Giulia Renda; Francesca Santilli; Paolo Calabrò; Alberto Ranieri De Caterina; Ilaria Cavallari; Elisabetta Ricottini; Vito Maurizio Parato; Giacomo Zoppellaro; Giuseppe Di Gioia; Pietro Sedati; Vincenzo Cicchitti; Giovanni Davì; Enrica Golia; Ivana Pariggiano; Paola Simeone; Rosanna Abbate; Domenico Prisco; Marco Zimarino; Francesco Sofi; Felicita Andreotti; Raffaele De Caterina
Journal:  Eur Heart J       Date:  2017-03-21       Impact factor: 29.983

Review 5.  Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation.

Authors:  J L Blackshear; J A Odell
Journal:  Ann Thorac Surg       Date:  1996-02       Impact factor: 4.330

  5 in total
  1 in total

1.  Isolated surgical left atrial appendage closure: Revisiting utility and indications in a burgeoning era of percutaneous therapy.

Authors:  Paula M Hernandez; Sanjay Divakaran; Dale S Adler; Daniel R Storms; Tsuyoshi Kaneko; Bibhu D Mohanty
Journal:  J Card Surg       Date:  2020-04-25       Impact factor: 1.620

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.